About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 284751, 14 pages
http://dx.doi.org/10.1155/2012/284751
Review Article

Non-MHC Risk Alleles in Rheumatoid Arthritis and in the Syntenic Chromosome Regions of Corresponding Animal Models

1Department of Rheumatology, Faculty of Medicine, Medical and Health Science Centre, University of Debrecen, Debrecen 4012, Hungary
2Section of Molecular Medicine, Departments of Orthopedic Surgery, Biochemistry, and Rheumatology, Rush University Medical Center, Chicago, IL 60612, USA

Received 12 June 2012; Revised 13 August 2012; Accepted 30 September 2012

Academic Editor: Mohammed Tikly

Copyright © 2012 Timea Besenyei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Kurko, T. Besenyei, J. Laki, et al., “Genetics of rheumatoid arthritis,” Clinical Reviews in Allergy & Immunology. In press.
  2. W. B. V. D. Berg, “Lessons from animal models of arthritis over the past decade,” Arthritis Research and Therapy, vol. 11, no. 5, article 250, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Ahlqvist, M. Hultqvist, and R. Holmdahl, “The value of animal models in predicting genetic susceptibility to complex diseases such as rheumatoid arthritis,” Arthritis Research and Therapy, vol. 11, no. 3, article 226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Bevaart, M. J. Vervoordeldonk, and P. P. Tak, “Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis?” Arthritis and Rheumatism, vol. 62, no. 8, pp. 2192–2205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Cai and A. La Cava, “Mimicking self-antigens with synthetic peptides in systemic autoimmune rheumatic diseases,” Current Clinical Pharmacology, vol. 4, no. 2, pp. 142–147, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. T. T. Glant, K. Mikecz, A. Arzoumanian, and A. R. Poole, “Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology,” Arthritis and Rheumatism, vol. 30, no. 2, pp. 201–212, 1987. View at Scopus
  7. K. Mikecz, T. T. Glant, and A. R. Poole, “Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan,” Arthritis and Rheumatism, vol. 30, no. 3, pp. 306–318, 1987. View at Scopus
  8. D. E. Trentham, A. S. Townes, and A. H. Kang, “Autoimmunity to type II collagen: an experimental model of arthritis,” Journal of Experimental Medicine, vol. 146, no. 3, pp. 857–868, 1977. View at Scopus
  9. J. S. Courtenay, M. J. Dallman, and A. D. Dayan, “Immunisation against heterologous type II collagen induces arthritis in mice,” Nature, vol. 283, no. 5748, pp. 666–668, 1980. View at Scopus
  10. T. T. Glant, A. Finnegan, and K. Mikecz, “Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics,” Critical Reviews in Immunology, vol. 23, no. 3, pp. 199–250, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Popovic, E. Ahlqvist, E. Rockenbauer, R. Bockermann, and R. Holmdahl, “Identification of new loci controlling collagen-induced arthritis in mouse using a partial advanced intercross and congenic strains,” Scandinavian Journal of Immunology, vol. 68, no. 4, pp. 405–413, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Zanelli, F. C. Breedveld, and R. R. P. De Vries, “HLA class II association with rheumatoid arthritis: facts and interpretations,” Human Immunology, vol. 61, no. 12, pp. 1254–1261, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. C. M. Weyand and J. J. Goronzy, “Association of MHC and rheumatoid arthritis HLA polymorphisms in phenotypic variants of rheumatoid arthritis,” Arthritis Research, vol. 2, no. 3, pp. 212–216, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. R. M. Plenge, “Rheumatoid arthritis genetics: 2009 update,” Current Rheumatology Reports, vol. 11, no. 5, pp. 351–356, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Bax, J. Van Heemst, T. W. J. Huizinga, and R. E. M. Toes, “Genetics of rheumatoid arthritis: what have we learned?” Immunogenetics, vol. 63, no. 8, pp. 459–466, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Perricone, F. Ceccarelli, and G. Valesini, “An overview on the genetic of rheumatoid arthritis: a never-ending story,” Autoimmunity Reviews, vol. 10, no. 10, pp. 599–608, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Craddock, M. E. Hurles, N. Cardin, et al., “Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls,” Nature, vol. 464, no. 7289, pp. 713–720, 2010.
  18. F. Cong, S. Spencer, J. F. Côté et al., “Cytoskeletal protein PSTPIP1 directs the PEST-type protein tyrosine phosphatase to the c-Abl kinase to mediate Abl dephosphorylation,” Molecular Cell, vol. 6, no. 6, pp. 1413–1423, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. E. A. Stahl, S. Raychaudhuri, E. F. Remmers, et al., “Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci,” Nature Genetics, vol. 42, no. 6, pp. 508–514, 2010.
  20. R. de Vries, “Genetics of rheumatoid arthritis: time for a change!,” Current Opinion in Rheumatology, vol. 23, no. 3, pp. 227–232, 2011.
  21. M. R. Velaga, V. Wilson, C. E. Jennings et al., “The codon 620 tryptophan allele of the Lymphoid Tyrosine Phosphatase (LYP) gene is a major determinant of Graves' disease,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5862–5865, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Smyth, J. D. Cooper, J. E. Collins et al., “Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus,” Diabetes, vol. 53, no. 11, pp. 3020–3023, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. L. A. Criswell, K. A. Pfeiffer, R. F. Lum et al., “Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes,” American Journal of Human Genetics, vol. 76, no. 4, pp. 561–571, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Hinks, A. Barton, S. John et al., “Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene,” Arthritis and Rheumatism, vol. 52, no. 6, pp. 1694–1699, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. M. K. Viken, S. S. Amundsen, T. K. Kvien et al., “Association analysis of the 1858C > T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases,” Genes and Immunity, vol. 6, no. 3, pp. 271–273, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. P. L. De Jager, S. Sawcer, A. Waliszewska et al., “Evaluating the role of the 620W allele of protein tyrosine phosphatase PTPN22 in Crohn's disease and multiple sclerosis,” European Journal of Human Genetics, vol. 14, no. 3, pp. 317–321, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Vandiedonck, C. Capdevielle, M. Giraud et al., “Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis,” Annals of Neurology, vol. 59, no. 2, pp. 404–407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Centola, Z. Szekanecz, E. Kiss et al., “Gene expression profiles of systemic lupus erythematosus and rheumatoid arthritis,” Expert Review of Clinical Immunology, vol. 3, no. 5, pp. 797–806, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M. J. H. Coenen and P. K. Gregersen, “Rheumatoid arthritis: a view of the current genetic landscape,” Genes and Immunity, vol. 10, no. 2, pp. 101–111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. D. D. Brand, A. H. Kang, and E. F. Rosloniec, “Immunopathogenesis of collagen arthritis,” Springer Seminars in Immunopathology, vol. 25, no. 1, pp. 3–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Hanyecz, S. E. Berlo, S. Szántó, C. P. M. Broeren, K. Mikecz, and T. T. Glant, “Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype,” Arthritis and Rheumatism, vol. 50, no. 5, pp. 1665–1676, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. V. Kouskoff, A. S. Korganow, V. Duchatelle, C. Degott, C. Benoist, and D. Mathis, “Organ-specific disease provoked by systemic autoimmunity,” Cell, vol. 87, no. 5, pp. 811–822, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. A. S. Korganow, J. Hong, S. Mangialaio et al., “From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins,” Immunity, vol. 10, no. 4, pp. 451–461, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Mangialaio, H. Ji, A. S. Korganow, et al., “The arthritogenic T cell receptor and its ligand in a model of spontaneous arthritis,” Arthritis and Rheumatism, vol. 42, no. 12, pp. 2517–2523, 1999.
  35. I. Matsumoto, M. Maccioni, D. M. Lee et al., “How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease,” Nature Immunology, vol. 3, no. 4, pp. 360–365, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Kassahn, C. Kolb, S. Solomon et al., “Few human autoimmune sera detect GPI (multiple letters) [2],” Nature Immunology, vol. 3, no. 5, pp. 411–413, 2002. View at Scopus
  37. D. Kassahn, C. Kolb, S. Solomon et al., “Few human autoimmune sera detect GPI (multiple letters),” Nature Immunology, vol. 3, no. 5, pp. 411–413, 2002. View at Scopus
  38. I. Matsumoto, D. M. Lee, R. Goldbach-Mansky et al., “Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders,” Arthritis and Rheumatism, vol. 48, no. 4, pp. 944–954, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. A. K. Johnsen, W. Valdar, L. Golden, et al., “A genome-wide and species-wide dissection of the genetics of arthritis severity in hetrogeneous stock mice,” Arthritis and Rheumatism, vol. 63, no. 9, pp. 2630–2640, 2011.
  40. N. Sakaguchi, T. Takahashi, H. Hata et al., “Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice,” Nature, vol. 426, no. 6965, pp. 454–460, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Horai, S. Saijo, H. Tanioka et al., “Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin I receptor antagonist-deficient mice,” Journal of Experimental Medicine, vol. 191, no. 2, pp. 313–320, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Nakae, S. Saijo, R. Horai, K. Sudo, S. Mori, and Y. Iwakura, “IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 10, pp. 5986–5990, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Keffer, L. Probert, H. Cazlaris et al., “Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis,” EMBO Journal, vol. 10, no. 13, pp. 4025–4031, 1991. View at Scopus
  44. S. Solomon, N. Rajasekaran, E. Jeisy-Walder, S. B. Snapper, and H. Illges, “A crucial role for macrophages in the pathology of K/B × N serum-induced arthritis,” European Journal of Immunology, vol. 35, no. 10, pp. 3064–3073, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. J. M. Stuart and F. J. Dixon, “Serum transfer of collagen-induced arthritis in mice,” Journal of Experimental Medicine, vol. 158, no. 2, pp. 378–392, 1983. View at Scopus
  46. M. E. Englert, K. M. Ferguson, and C. R. Suarez, “Passive transfer of collagen arthritis: heterogeneity of anti-collagen IgG,” Cellular Immunology, vol. 101, no. 2, pp. 373–379, 1986. View at Scopus
  47. R. Holmdahl, L. Klareskog, and K. Rubin, “T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones,” Scandinavian Journal of Immunology, vol. 22, no. 3, pp. 295–306, 1985. View at Scopus
  48. O. Tarjanyi, F. Boldizsar, P. Nemeth, K. Mikecz, and T. T. Glant, “Age-related changes in arthritis susceptibility and severity in a murine model of rheumatoid arthritis,” Immunity and Ageing, vol. 6, article 8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. T. T. Glant, M. Radacs, G. Nagyeri et al., “Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 63, no. 5, pp. 1312–1321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Zhang, A. Guerassimov, J. Y. Leroux et al., “Induction of arthritis in BALB/c mice by cartilage link protein: involvement of distinct regions recognized by T and B lymphocytes,” American Journal of Pathology, vol. 153, no. 4, pp. 1283–1291, 1998. View at Scopus
  51. G. F. M. Verheijden, A. W. M. Rijnders, E. Bos et al., “Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 40, no. 6, pp. 1115–1125, 1997. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Bárdos, J. Zhang, K. Mikecz, C. S. David, and T. T. Glant, “Mice lacking endogenous major histocompatibility complex class II develop arthritis resembling psoriatic arthritis at an advanced age,” Arthritis and Rheumatism, vol. 46, no. 9, pp. 2465–2475, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. S. E. Berlo, P. J. Van Kooten, C. B. Ten Brink et al., “Naive transgenic T cells expressing cartilage proteoglycan-specific TCR induce arthritis upon in vivo activation,” Journal of Autoimmunity, vol. 25, no. 3, pp. 172–180, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. S. E. Berlo, T. Guichelaar, C. B. Ten Brink et al., “Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice,” Arthritis and Rheumatism, vol. 54, no. 8, pp. 2423–2433, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. F. Boldizsar, K. Kis-Toth, O. Tarjanyi et al., “Impaired activation-induced cell death promotes spontaneous arthritis in antigen (cartilage proteoglycan)-specific T cell receptor-transgenic mice,” Arthritis and Rheumatism, vol. 62, no. 10, pp. 2984–2994, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. J. R. Jensen, L. C. Peters, A. Borrego et al., “Involvement of antibody production quantitative trait loci in the susceptibility to pristane-induced arthritis in the mouse,” Genes and Immunity, vol. 7, no. 1, pp. 44–50, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. X. Yu, K. Bauer, D. Koczan, H. J. Thiesen, and S. M. Ibrahim, “Combining global genome and transcriptome approaches to identify the candidate genes of small-effect quantitative trait loci in collagen-induced arthritis,” Arthritis Research and Therapy, vol. 9, article R3, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. X. Yu, H. Teng, A. Marques, F. Ashgari, and S. M. Ibrahim, “High resolution mapping of Cia3: a common arthritis quantitative trait loci in different species,” Journal of Immunology, vol. 182, no. 5, pp. 3016–3023, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. A. R. Poole, “Cartilage in health and disease,” in Arthritis and Allied Conditions. A Textbook of Rheumatology, D. J. McCarty and W. J. Koopman, Eds., pp. 279–333, Lea & Febiger, Philadelphia, Pa, USA, 1993.
  60. M. Czipri, J. M. Otto, G. Cs-Szabó et al., “Genetic rescue of chondrodysplasia and the perinatal lethal effect of cartilage link protein deficiency,” Journal of Biological Chemistry, vol. 278, no. 40, pp. 39214–39223, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. I. I. Singer, D. W. Kawka, E. K. Bayne et al., “VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis,” Journal of Clinical Investigation, vol. 95, no. 5, pp. 2178–2186, 1995. View at Scopus
  62. N. Bizzaro, “Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis,” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 2, pp. 150–157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Simon, E. Girbal, M. Sebbag et al., “The cytokeratin filament-aggregating protein filaggrin is the target of the so-called 'antikeratin antibodies,' autoantibodies specific for rheumatoid arthritis,” Journal of Clinical Investigation, vol. 92, no. 3, pp. 1387–1393, 1993. View at Scopus
  64. E. Girbal-Neuhauser, J. J. Durieux, M. Arnaud et al., “The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues,” Journal of Immunology, vol. 162, no. 1, pp. 585–594, 1999. View at Scopus
  65. A. R. Poole, T. T. Glant, and K. Mikecz, “Autoimmunity to cartilage collagen and proteoglycan and the development of chronic inflammatory arthritis,” in The Control of Tissue Damage, A. M. Glaurer, Ed., pp. 55–65, Elsevier Publishers (Biomedical Division), Amsterdam, The Netherlands, 1988.
  66. T. T. Glant, K. Mikecz, E. J. M. A. Thonar, and K. E. Kuettner, “Immune responses to cartilage proteoglycans in inflammatory animal models and human diseases,” in Cartilage Degradation: Basic and Clinical Aspects, J. F. Woessner and D. S. Howell, Eds., pp. 435–473, Marcel Dekker, New York, NY, USA, 1992.
  67. T. T. Glant, C. Fulop, K. Mikecz, E. Buzas, G. Molnar, and P. Erhardt, “Proteoglycan-specific autoreactive antibodies and T-lymphocytes in experimental arthritis and human rheumatoid joint diseases,” Biochemical Society Transactions, vol. 18, no. 5, pp. 796–799, 1990. View at Scopus
  68. J. H. Herman, D. W. Wiltse, and M. V. Dennis, “Immunopathologic significance of cartilage antigenic components in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 16, no. 3, pp. 287–297, 1973. View at Scopus
  69. T. Glant, J. Csongor, and T. Szucs, “Immunopathologic role of proteoglycan antigens in rheumatoid joint disease,” Scandinavian Journal of Immunology, vol. 11, no. 3, pp. 247–252, 1980. View at Scopus
  70. E. E. Golds, I. B. M. Stephen, and J. M. Esdaile, “Lymphocyte transformation to connective tissue antigens in adult and juvenile rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, systemic lupus erythematosus, and a nonarthritic control population,” Cellular Immunology, vol. 82, no. 1, pp. 196–209, 1983. View at Scopus
  71. C. Karopoulos, M. J. Rowley, M. Z. Ilic, and C. J. Handley, “Presence of antibodies to native G1 domain of aggrecan core protein in synovial fluids from patients with various joint diseases,” Arthritis and Rheumatism, vol. 39, no. 12, pp. 1990–1997, 1996. View at Publisher · View at Google Scholar · View at Scopus
  72. A. M. H. Boots, G. F. M. Verheijden, R. Schöningh et al., “Selection of self-reactive peptides within human aggrecan by use of a HLA-DRB1*0401 peptide binding motif,” Journal of Autoimmunity, vol. 10, no. 6, pp. 569–578, 1997. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Guerassimov, Y. Zhang, S. Banerjee et al., “Autoimmunity to cartilage link protein in patients with rheumatoid arthritis and ankylosing spondylitis,” Journal of Rheumatology, vol. 25, no. 8, pp. 1480–1484, 1998. View at Scopus
  74. A. Guerassimov, Y. P. Zhang, S. Banerjee, et al., “Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate,” Arthritis and Rheumatism, vol. 41, no. 6, pp. 1019–1025, 1998.
  75. N. L. Li, D. Q. Zhang, K. Y. Zhou et al., “Isolation and characteristics of autoreactive T cells specific to aggrecan G1 domain from rheumatoid arthritis patients,” Cell Research, vol. 10, no. 1, pp. 39–49, 2000. View at Scopus
  76. J. Zou, Y. Zhang, A. Thiel et al., “Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis,” Rheumatology, vol. 42, no. 7, pp. 846–855, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. H. De Jong, S. E. Berlo, P. Hombrink et al., “Cartilage proteoglycan aggrecan epitopes induce proinflammatory autoreactive T-cell responses in rheumatoid arthritis and osteoarthritis,” Annals of the Rheumatic Diseases, vol. 69, no. 1, pp. 255–262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Von Delwig, J. Locke, J. H. Robinson, and W. F. Ng, “Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 62, no. 1, pp. 143–149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. S. C. Law, S. Street, C. H. Yu, et al., “T cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles,” Arthritis Research and Therapy, vol. 14, no. 3, p. R118, 2012.
  80. E. I. Buzás, A. Hanyecz, Y. Murad et al., “Differential recognition of altered peptide ligands distinguishes two functionally discordant (arthritogenic and nonarthritogenic) autoreactive T cell hybridoma clones,” Journal of Immunology, vol. 171, no. 6, pp. 3025–3033, 2003. View at Scopus
  81. E. I. Buzás, A. Végvári, Y. M. Murad, A. Finnegan, K. Mikecz, and T. T. Glant, “T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis,” Cellular Immunology, vol. 235, no. 2, pp. 98–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. T. T. Glant, V. A. Adarichev, A. B. Nesterovitch et al., “Disease-associated qualitative and quantitative trait loci in proteoglycan-induced arthritis and collagen-induced arthritis,” American Journal of the Medical Sciences, vol. 327, no. 4, pp. 188–195, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. J. M. Otto, G. Cs-Szabó, J. Gallagher, et al., “Identification of multiple loci linked to inflammation and autoantibody production by a genome scan of a murine model of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 42, no. 12, pp. 2524–2531, 1999.
  84. T. T. Glant, V. A. Adarichev, F. Boldizsar, et al., “Disease-promoting and -protective genomic loci on mouse chromosomes 3 and 19 control the incidence and severity of autoimmune arthritis,” Gene Immunity, vol. 13, no. 4, pp. 336–345, 2012.
  85. V. A. Adarichev, T. Bárdos, S. Christodoulou, M. T. Phillips, K. Mikecz, and T. T. Glant, “Major histocompatibility complex controls susceptibility and dominant inheritance, but not the severity of the disease in mouse models of rheumatoid arthritis,” Immunogenetics, vol. 54, no. 3, pp. 184–192, 2002. View at Publisher · View at Google Scholar · View at Scopus
  86. V. A. Adarichev, J. C. Valdez, T. Bárdos, A. Finnegan, K. Mikecz, and T. T. Glant, “Combined autoimmune models of arthritis reveal shared and independent qualitative (binary) and quantitative trait loci,” Journal of Immunology, vol. 170, no. 5, pp. 2283–2292, 2003. View at Scopus
  87. V. A. Adarichev, A. Vegvari, Z. Szabo, K. Kis-Toth, K. Mikecz, and T. T. Glant, “Congenic strains displaying similar clinical phenotype of arthritis represent different immunologic models of inflammation,” Genes and Immunity, vol. 9, no. 7, pp. 591–601, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. R. M. Plenge, M. Seielstad, L. Padyukov et al., “TRAF1-C5 as a risk locus for rheumatoid arthritis - A genomewide study,” The New England Journal of Medicine, vol. 357, no. 12, pp. 1199–1209, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. C. J. Etzel, W. V. Chen, N. Shepard et al., “Genome-wide meta-analysis for rheumatoid arthritis,” Human Genetics, vol. 119, no. 6, pp. 634–641, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. A. Barton, W. Thomson, X. Ke et al., “Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility,” Human Molecular Genetics, vol. 17, no. 15, pp. 2274–2279, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. H. Eleftherohorinou, V. Wright, C. Hoggart et al., “Pathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases.,” PloS One, vol. 4, no. 11, article e8068, 2009. View at Scopus
  92. T. T. Glant, S. Szántó, A. Vegvari et al., “Two loci on chromosome 15 control experimentally induced arthritis through the differential regulation of IL-6 and lymphocyte proliferation,” Journal of Immunology, vol. 181, no. 2, pp. 1307–1314, 2008. View at Scopus
  93. E. Ahlqvist, R. Bockermann, and R. Holmdahl, “Fragmentation of two quantitative trait loci controlling collagen-induced arthritis reveals a new set of interacting subloci,” Journal of Immunology, vol. 178, no. 5, pp. 3084–3090, 2007. View at Scopus
  94. M. Liljander, M. A. Sällström, S. Anderson, et al., “Identification of collagen-induced arthritis loci in aged multiparous female mice,” Arthritis Research and Therapy, vol. 8, no. 2, article R45, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. K. Bauer, X. Yu, P. Wernhoff, D. Koczan, H. J. Thiesen, and S. M. Ibrahim, “Identification of new quantitative trait loci in mice with collagen-induced arthritis,” Arthritis and Rheumatism, vol. 50, no. 11, pp. 3721–3728, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. X. Yu, K. Bauer, P. Wernhoff et al., “Fine mapping of collagen-induced arthritis quantitative trait loci in an advanced intercross line,” Journal of Immunology, vol. 177, no. 10, pp. 7042–7049, 2006. View at Scopus
  97. M. Johannesson, L. M. Olsson, A. K. B. Lindqvist et al., “Gene expression profiling of arthritis using a QTL chip reveals a complex gene regulation of the Cia5 region in mice,” Genes and Immunity, vol. 6, no. 7, pp. 575–583, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. T. Lindvall, J. Karlsson, R. Holmdahl, et al., “Dissection of a locus on mouse chromosome 5 reveals arthritis promoting and inhibitory genes,” Arthritis Research and Therapy, vol. 11, no. 1, article R10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  99. S. M. Ibrahim, D. Koczan, and H. J. Thiesen, “Gene-expression profile of collagen-induced arthritis,” Journal of Autoimmunity, vol. 18, no. 2, pp. 159–167, 2002. View at Publisher · View at Google Scholar · View at Scopus
  100. P. S. Gulko, Y. Kawahito, E. F. Remmers, et al., “Identification of a new non-major histocompatibility complex genetic locus on chromosome 2 that controls disease severity in collagen-induced arthritis in rats,” Arthritis and Rheumatism, vol. 41, no. 12, pp. 2122–2131, 1998.
  101. Y. Kawahito, E. F. Remmers, R. L. Wilder et al., “A genetic linkage map of rat chromosome 20 derived from five F2 crosses,” Immunogenetics, vol. 48, no. 5, pp. 335–338, 1998. View at Publisher · View at Google Scholar · View at Scopus
  102. J. S. Shepard, E. F. Remmers, S. Chen et al., “A genetic linkage map of rat Chromosome 15 derived from five F2 crosses,” Mammalian Genome, vol. 10, no. 2, pp. 186–188, 1999. View at Publisher · View at Google Scholar · View at Scopus
  103. B. Joe, E. F. Remmers, D. E. Dobbins et al., “Genetic dissection of collagen-induced arthritis in chromosome 10 quantitative trait locus speed congenic rats: evidence for more than one regulatory locus and sex influences,” Immunogenetics, vol. 51, no. 11, pp. 930–944, 2000. View at Publisher · View at Google Scholar · View at Scopus
  104. L. Wester, P. Olofsson, S. M. Ibrahim, and R. Holmdahl, “Chronicity of pristane-induced arthritis in rats is controlled by genes on chromosome 14,” Journal of Autoimmunity, vol. 21, no. 4, pp. 305–313, 2003. View at Publisher · View at Google Scholar · View at Scopus
  105. L. Wester, D. Koczan, J. Holmberg et al., “Differential gene expression in pristane-induced arthritis susceptible DA versus resistant E3 rats,” Arthritis Research & Therapy, vol. 5, no. 6, pp. R361–R372, 2003. View at Scopus
  106. V. A. Adarichev, A. B. Nesterovitch, T. Bárdos et al., “Sex effect on clinical and immunologic quantitative trait loci in a murine model of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 48, no. 6, pp. 1708–1720, 2003. View at Publisher · View at Google Scholar · View at Scopus
  107. J. M. Otto, R. Chandrasekeran, C. Vermes et al., “A genome scan using a novel genetic cross identifies new susceptibility loci and traits in a mouse model of rheumatoid arthritis,” Journal of Immunology, vol. 165, no. 9, pp. 5278–5286, 2000. View at Scopus
  108. M. Johannesson, J. Karlsson, P. Wernhoff et al., “Identification of epistasis through a partial advanced intercross reveals three arthritis loci within the Cia5 QTL in mice,” Genes and Immunity, vol. 6, no. 3, pp. 175–185, 2005. View at Publisher · View at Google Scholar · View at Scopus
  109. G. Firneisz, I. Zehavi, C. Vermes, A. Hanyecz, J. A. Frieman, and T. T. Glant, “Identification and quantification of disease-related gene clusters,” Bioinformatics, vol. 19, no. 14, pp. 1781–1786, 2003. View at Publisher · View at Google Scholar · View at Scopus
  110. H. T. Yang, J. Jirholt, L. Svensson et al., “Identification of genes controlling collagen-induced arthritis in mice: striking homology with susceptibility loci previously identified in the rat,” Journal of Immunology, vol. 163, no. 5, pp. 2916–2921, 1999. View at Scopus
  111. N. Van Houten and S. F. Blake, “Direct measurement of anergy of antigen-specific T cells following oral tolerance induction,” Journal of Immunology, vol. 157, no. 4, pp. 1337–1341, 1996. View at Scopus
  112. D. R. Studelska, L. Mandik-Nayak, X. Zhou et al., “High affinity glycosaminoglycan and autoantigen interaction explains joint specificity in a mouse model of rheumatoid arthritis,” Journal of Biological Chemistry, vol. 284, no. 4, pp. 2354–2362, 2009. View at Publisher · View at Google Scholar · View at Scopus
  113. L. B. Hughes, R. J. Reynolds, E. E. Brown et al., “Most common single-nucleotide polymorphisms associated with rheumatoid arthritis in persons of European ancestry confer risk of rheumatoid arthritis in African Americans,” Arthritis and Rheumatism, vol. 62, no. 12, pp. 3547–3553, 2010. View at Publisher · View at Google Scholar · View at Scopus
  114. J. Cui, S. Saevarsdottir, B. Thomson et al., “Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor α therapy,” Arthritis and Rheumatism, vol. 62, no. 7, pp. 1849–1861, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. S. D. Thompson, M. Sudman, P. S. Ramos et al., “The susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1,” Arthritis and Rheumatism, vol. 62, no. 11, pp. 3265–3276, 2010. View at Publisher · View at Google Scholar · View at Scopus
  116. A. W. Morgan, J. I. Robinson, P. G. Conaghan et al., “Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4 and TRAF1/C5 in an inception cohort,” Arthritis Research and Therapy, vol. 12, no. 2, article R57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. J. Freudenberg, H. S. Lee, B. G. Han et al., “Genome-Wide Association Study of Rheumatoid Arthritis in Koreans: population-specific loci as well as overlap with European Susceptibility Loci,” Arthritis and Rheumatism, vol. 63, no. 4, pp. 884–893, 2011. View at Publisher · View at Google Scholar · View at Scopus
  118. R. M. Plenge, C. Cotsapas, L. Davies et al., “Two independent alleles at 6q23 associated with risk of rheumatoid arthritis,” Nature Genetics, vol. 39, no. 12, pp. 1477–1482, 2007. View at Publisher · View at Google Scholar · View at Scopus
  119. M. Feldmann, F. M. Brennan, and R. N. Maini, “Role of cytokines in rheumatoid arthritis,” Annual Review of Immunology, vol. 14, pp. 397–440, 1996. View at Publisher · View at Google Scholar · View at Scopus
  120. L. Menard, D. Saadoun, I. Isnardi, et al., “The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans,” The Journal of Clinical Investigation, vol. 121, no. 9, pp. 3635–3644, 2011.
  121. J. Jirholt, A. Cook, T. Emahazion, et al., “Genetic linkage analysis of collagen-induced arthritis in the mouse,” European Journal of Immunology, vol. 28, no. 10, pp. 3321–3328, 1998.
  122. M. Sundvall, J. Jirholt, H. T. Yang et al., “Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis,” Nature Genetics, vol. 10, no. 3, pp. 313–317, 1995. View at Scopus
  123. J. Karlsson, M. Johannesson, T. Lindvall, et al., “Genetic interactions in Eae2 control collagen-induced arthritis and the CD4+/CD8+ T cell ratio,” Journal of Immunology, vol. 174, no. 1, pp. 533–541, 2005. View at Scopus
  124. H. C. Meng, M. M. Griffiths, E. F. Remmers et al., “Identification of two novel female-specific non-major histocompatibility complex loci regulating collagen-induced arthritis severity and chronicity, and evidence of epistasis,” Arthritis and Rheumatism, vol. 50, no. 8, pp. 2695–2705, 2004. View at Publisher · View at Google Scholar · View at Scopus
  125. M. Brenner, H. C. Meng, N. C. Yarlett et al., “The non-major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation, and joint damage,” Arthritis and Rheumatism, vol. 52, no. 1, pp. 322–332, 2005. View at Publisher · View at Google Scholar · View at Scopus
  126. W. Xu, H. Lan, P. Hu, et al., “Evidence of linkage to chromosome 1 for early age of onset of rheumatoid arthritis and HLA marker DRB1 genotype in NARAC data,” BMC Proceedings, vol. 1, supplement 1, p. S78, 2007.
  127. C. Liu, F. Batliwalla, W. Li et al., “Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis,” Molecular Medicine, vol. 14, no. 9-10, pp. 575–581, 2008. View at Publisher · View at Google Scholar · View at Scopus
  128. M. Gharaee-Kermani, E. M. Denholm, and S. H. Phan, “Costimulation of fibroblast collagen and transforming growth factor β1 gene expression by monocyte chemoattractant protein-1 via specific receptors,” Journal of Biological Chemistry, vol. 271, no. 30, pp. 17779–17784, 1996. View at Publisher · View at Google Scholar · View at Scopus
  129. A. H. M. van der Helm-van Mil and T. W. J. Huizinga, “Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets,” Arthritis Research and Therapy, vol. 10, no. 2, article 205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  130. J. Bowes and A. Barton, “Recent advances in the genetics of RA susceptibility,” Rheumatology, vol. 47, no. 4, pp. 399–402, 2008. View at Publisher · View at Google Scholar · View at Scopus
  131. S. J. Choi, Y. H. Rho, J. D. Ji, G. G. Song, and Y. H. Lee, “Genome scan meta-analysis of rheumatoid arthritis,” Rheumatology, vol. 45, no. 2, pp. 166–170, 2006. View at Publisher · View at Google Scholar · View at Scopus
  132. A. W. Morgan, J. H. Barrett, B. Griffiths et al., “Analysis of Fcgamma receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B,” Arthritis Research & Therapy, vol. 8, no. 1, p. R5, 2006. View at Scopus
  133. Y. Kochi, R. Yamada, A. Suzuki et al., “A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities,” Nature Genetics, vol. 37, no. 5, pp. 478–485, 2005. View at Publisher · View at Google Scholar · View at Scopus
  134. D. D. Licatalosi, A. Mele, J. J. Fak et al., “HITS-CLIP yields genome-wide insights into brain alternative RNA processing,” Nature, vol. 456, no. 7221, pp. 464–469, 2008. View at Publisher · View at Google Scholar · View at Scopus
  135. S. W. Chi, J. B. Zang, A. Mele, and R. B. Darnell, “Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps,” Nature, vol. 460, no. 7254, pp. 479–486, 2009. View at Publisher · View at Google Scholar · View at Scopus
  136. G. Malterer, L. Dölken, and J. Haas, “The miRNA-targetome of KSHV and EBV in human B-cells,” RNA Biology, vol. 8, no. 1, pp. 30–34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  137. J. Wen, B. J. Parker, A. Jacobsen, and A. Krogh, “MicroRNA transfection and AGO-bound CLIP-seq data sets reveal distinct determinants of miRNA action,” RNA, vol. 17, no. 5, pp. 820–834, 2011. View at Publisher · View at Google Scholar · View at Scopus
  138. C. Zhang and R. B. Darnell, “Mapping in vivo protein-RNA interactions at single-nucleotide resolution from HITS-CLIP data,” Nature Biotechnology, vol. 29, no. 7, pp. 607–614, 2011. View at Publisher · View at Google Scholar · View at Scopus